accessibility menu, dialog, popup

UserName
Viewing profile as user:

Pentacenequinones

Polycyclic aromatic hydrocarbon compounds that consist of twenty-two carbon atoms and twenty-four hydrogen atoms linearly fused into five benzene rings, and an even number of carbonyl functional groups.

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (2)
  • (1)

special interests

  • (2)

Search Within Results
Keyword Search:
1 – 3 of 3 results
1

Selleck Chemical LLC SR-3029

SR-3029 is a potent and selective casein kinase 1 /1 (CK1 / ) inhibitor with IC50 values of 44 and 260 nM for CK1 and CK1 respectively

ENCOMPASS_PREFERRED
2

Medchemexpress LLC N-((6,7-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 | C23H19F3N8O | 100 MG
SDP

SR-3029 is a small-molecule, ATP-competitive inhibitor of casein kinase 1 delta (CK1δ) and casein kinase 1 epsilon (CK1ε), intended for research use in biochemical and cell-based studies. It exhibits potent enzyme inhibition and is provided in formats suitable for assay and formulation work.

  • Potent ATP-competitive inhibition of CK1δ and CK1ε.
  • Low-nanomolar activity against CK1δ (IC50 44 nM).
  • Sub-micromolar activity against CK1ε (IC50 260 nM).
  • Ki of 97 nM for both CK1δ and CK1ε.
  • Chemical formula C23H19F3N8O and molecular weight 480.45.
  • High purity (99.7%) suitable for research applications.
  • Available as solid and as DMSO solution for experimental flexibility.

ENCOMPASS_PREFERRED
3

Medchemexpress LLC N-((6,7-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine | 1454585-06-8 | MFCD30187527 | 99.7% | 480.45 | C23H19F3N8O | 5 MG
SDP

SR-3029 is a small-molecule, ATP-competitive inhibitor selective for casein kinase 1 delta and epsilon (CK1δ/CK1ε). It is used as a research tool compound to study CK1-dependent signaling pathways and to evaluate antiproliferative effects in preclinical models.

  • Selective CK1δ/CK1ε inhibition with IC50 values in the low-nanomolar range.
  • ATP-competitive mechanism useful for kinase-targeting studies.
  • High chemical purity (99.73%).
  • Supplied as a solid suitable for formulation and in vitro assays.
  • Well-characterized structural identifiers (CAS, SMILES, MFCD) for unambiguous identification.

ENCOMPASS_PREFERRED